Skip to Main Content (Press Enter)

Logo UNIMORE
  • ×
  • Home
  • Degree programmes
  • Modules
  • Jobs
  • People
  • Research Outputs
  • Academic units
  • Third Mission
  • Projects
  • Skills

UNI-FIND
Logo UNIMORE

|

UNI-FIND

unimore.it
  • ×
  • Home
  • Degree programmes
  • Modules
  • Jobs
  • People
  • Research Outputs
  • Academic units
  • Third Mission
  • Projects
  • Skills
  1. Research Outputs

Hemoadsorption and plasma adsorption: two current options for the 3rd dimension of dialysis purification

Academic Article
Publication Date:
2025
Short description:
Hemoadsorption and plasma adsorption: two current options for the 3rd dimension of dialysis purification / Morisi, N.; Alfano, G.; Ferrarini, M.; Ferri, C.; Fontana, F.; Ballestri, M.; Donati, G.. - In: JN. JOURNAL OF NEPHROLOGY. - ISSN 1121-8428. - (2025), pp. 1-13. [10.1007/s40620-025-02257-x]
abstract:
The adsorption technique has opened a new frontier in the field of purification through hemodialysis. This technique has proved to be effective in removing uremic toxins previously deemed inaccessible due to their size or charge, as well as to their molecular interactions with blood proteins. In this context, this review provides a detailed explanation of the role of Polyester-polymer alloy (PEPA (R)) membranes and hemodiafiltration with endogenous reinfusion. The polyester-polymer alloy membrane is a three-layered dialysis membrane with adsorbent properties, representing an innovative approach to engineering the filter membrane to achieve adsorbent characteristics while maintaining biocompatibility with blood. Haemodiafiltration with endogenous reinfusion is a technique where a first filter separates plasma water from blood, then plasma water is led to a sorbent cartridge. After contact with the sorbent, the purified plasma water reconstitutes the whole blood, which is led to a second filter where diffusion takes place. Both techniques are efficacious in removing middle-molecular weight molecules and protein-bound toxins, and have a role in reducing inflammation and erythropoietin resistance. However, the additional clinical advantage of adsorption is partially offset by lack of selectivity in the absorption process, potentially resulting in the loss of micro- and macronutrients or drugs. Therefore, further studies are encouraged to evaluate the impact of absorption on patient outcomes and clinical applicability in certain medical conditions.
Iris type:
Articolo su rivista
Keywords:
HFR; Hemoadsorption; PEPA; Plasma adsorption; Uremic toxins
List of contributors:
Morisi, N.; Alfano, G.; Ferrarini, M.; Ferri, C.; Fontana, F.; Ballestri, M.; Donati, G.
Authors of the University:
Alfano Gaetano
Donati Gabriele
FONTANA FRANCESCO
MORISI NICCOLO'
Handle:
https://iris.unimore.it/handle/11380/1375151
Full Text:
https://iris.unimore.it//retrieve/handle/11380/1375151/781523/Morisi%20JN%20hemoadsorption%202025.pdf
Published in:
JN. JOURNAL OF NEPHROLOGY
Journal
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.4.4.0